Reach your audience. Get results.

Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.

Public Relations

Public Relations

Maximize the reach of your news with our press release distribution services and partnerships.

Investor Relations

Investor Relations

Reach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools.

Distribution and Analytics

Distribution & Analytics

Target your news, reach your audiences, and understand the impact of your press releases with our analytics reports.

News with Multimedia

Bristol-Myers Squibb Announces Dividend Increase

NEW YORK--()--The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a 3% percent increase in the company’s quarterly dividend, beginning in the first quarter of 2012.

The dividend increase will result in a quarterly dividend of thirty-four cents ($0.34) per share on the $.10 par value Common Stock of the corporation for an indicative 2012 full-year dividend of $1.36 per share, subject to the normal quarterly review by the Board. The next quarterly dividend will be payable on February 1, 2012, to stockholders of record at the close of business on January 6, 2012.

The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 1, 2012, to stockholders of record at the close of business on February 3, 2012.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contacts

Bristol-Myers Squibb
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

Recent Stories

RSS feed for Bristol-Myers Squibb Company

Release Versions

Company Information Center

Bristol-Myers Squibb Company RSS feed for Bristol-Myers Squibb Company

NYSE:BMY

More News with Multimedia

Latest News

Bristol-Myers Squibb Announces Dividend Increase

NEW YORK--()--The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a 3% percent increase in the company’s quarterly dividend, beginning in the first quarter of 2012.

The dividend increase will result in a quarterly dividend of thirty-four cents ($0.34) per share on the $.10 par value Common Stock of the corporation for an indicative 2012 full-year dividend of $1.36 per share, subject to the normal quarterly review by the Board. The next quarterly dividend will be payable on February 1, 2012, to stockholders of record at the close of business on January 6, 2012.

The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 1, 2012, to stockholders of record at the close of business on February 3, 2012.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contacts

Bristol-Myers Squibb
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

Recent Stories

RSS feed for Bristol-Myers Squibb Company

Release Versions

Company Information Center

Bristol-Myers Squibb Company RSS feed for Bristol-Myers Squibb Company

NYSE:BMY

All News